Alessio Branchini Shares His Latest Work on Albumin-Fused Factor IX Variants and Thanks The Whole Team
Alessio Branchini, Associate Professor of Molecular Biology at University of Ferrara, shared on LinkedIn:
”Very proud to announce that our paper is published!
Great and hard, but exciting, work on the characterization and biodistribution of engineered albumin-fused factor IX variants with tailored biinding to extravascular collagen.
Wonderful collaborations involving our group at the University of Ferrara, the team at the University of Oslo and the San Raffaele Hospital.
From the University of Ferrara side, excellent work by Maria Francesca Testa, Rebecca Tarantino and Mascia Benedusi.
Very thankful to Jan Terje Andersen, Kristin Hovden Aaen and Jeannette Nilsen (University of Oslo for the wonderful and ongoing collaboration (10 years!), to Alessio Cantore and Cesare Canepari (Ospedale San Raffaele) for their extremely valuable contribution, as well as to all collaborators.
Together we made this story possible.
Of course, a particular thank you to my (and our) mentors Francesco Bernardi and Mirko Pinotti at the University of Ferrara.
Last but not least, I am really grateful to the Access to Insight Basic Research Grant program by Novo Nordisk.
Press releases on Eurekalert and on the news site of University of Ferrara.”
Read the full article in Nature Communications.
Article: Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties
Authors: Kristin Hovden Aaen, Maria Francesca Testa, Jeannette Nilsen, Rebecca Tarantino, Cesare Canepari, Mascia Benedusi, Sopisa Benjakul, Mari Nyquist-Andersen, Marie Leangen Herigstad, Alessio Cantore, Giuseppe Valacchi, Inger Sandlie, Francesco Bernardi, Mirko Pinotti, Alessio Branchini, Jan Terje Andersen
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 14, 2026, 15:47An Unusual Case from Mohammed Ameen: Unexpected Clot Unmasking Antithrombin III Deficiency
-
Jan 14, 2026, 11:38Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke
-
Jan 14, 2026, 11:26Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy